128940.KS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 09:30):

Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases...

Stats
Dzisiejszy wolumen	30 150.00
Średni wolumen	42 462.00
Kapitalizacja rynkowa	4 041.17B
EPS	KRW0 ( 2024-04-23 )
Następna data zysków	( KRW3 611.06 ) 2024-04-30
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW465.36 (0.15%)

Wolumen Korelacja

Długi: -0.04 (neutral)

Krótki: 0.65 (weak)

Signal:(56.718) Neutral

Hanmi Pharm. Co., Ltd. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hanmi Pharm. Co., Ltd. Korelacja - Waluta/Towar

-0.10
( neutral )

-0.13
( neutral )

0.18
( neutral )

-0.09
( neutral )

-0.02
( neutral )

-0.34
( neutral )

Hanmi Pharm. Co., Ltd. Finanse

Annual	2023
Przychody:	KRW1 490.89B
Zysk brutto:	KRW835.86B (56.06 %)
EPS:	KRW11 522

FY	2023
Przychody:	KRW1 490.89B
Zysk brutto:	KRW835.86B (56.06 %)
EPS:	KRW11 522

FY	2022
Przychody:	KRW1 331.55B
Zysk brutto:	KRW718.55B (53.96 %)
EPS:	KRW6 517.20

FY	2021
Przychody:	KRW1 203.19B
Zysk brutto:	KRW632.75B (52.59 %)
EPS:	KRW5 585.96

Financial Reports:

No articles found.

Hanmi Pharm. Co., Ltd.

Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.

Aktualne aktualizacje dla Hanmi Pharm. Co., Ltd. [128940.KS]

Upcoming Earnings Alert